Bristol-Myers Squibb (BMY) Tops Q2 EPS by 1c; Raises FY11 Outlook
uibb Company (NYSE: BMY) reported Q2 EPS of $0.56, $0.01 better than the analyst estimate of $0.55. Revenue for the quarter came in at $5.4 billion versus the consensus estimate of $5.04 billion.
Sees FY2011 EPS of $2.20-$2.30, versus prior guidance of $2.10-$2.20 and the consensus of $2.21.